Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Solid Biosciences Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 8.35 · gapped above the open, then crossed back over prior close. High/low 8.48 at 9:30 am ET, 8.18 at 10:45 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“We will pay Jefferies a commission of up to 3% of the gross proceeds of any sales of common stock pursuant to the ATM Sales Agreement.”
FILING10-K0001193125-26-115928cik 0001707502
“In connection with the asset purchase agreement with FA212 LLC ("FA212"), certain development milestone payments to FA212 are payable in either cash, equity, or a combination of both, at our discretion.”
FILING10-K0001193125-26-115928cik 0001707502
“We have further licensed certain intellectual property from the University of Pennsylvania and others that are important or necessary to the development of SGT-212 and from ICS Maugeri that are important or necessary to the development of SGT-501.”
FILING10-K0001193125-26-115928cik 0001707502
“We have further licensed certain intellectual property from the University of Pennsylvania and others that are important or necessary to the development of SGT-212 and from ICS Maugeri that are important or necessary to the development of SGT-501.”
FILING10-K0001193125-26-115928cik 0001707502
“In 2015, we entered into a license agreement with the University of Washington, acting through UW CoMotion, under which we obtained an exclusive, royalty-bearing, sublicensable, worldwide license under certain patent applications owned by the University of Washington relating to novel micro-dystrophins to develop, manufacture, and commercialize products for use in the treatment of Duchenne and related disease indications caused by a lack of functional dystrophin.”
FILING10-K0001193125-26-115928cik 0001707502
“Pursuant to the Maugeri License Agreement, Maugeri granted us an exclusive worldwide sublicensable license in certain Maugeri patent rights, including existing patent rights, and those in any improvements or know-how made in performance of the Maugeri License Agreement, and a non-exclusive worldwide sublicensable license in certain Maugeri know-how, including existing know-how, and on any improvement thereto, in each case, subject to certain conditions, that is necessary or reasonably useful to develop licensed products under the terms of the Maugeri License Agreement.”
FILING10-K0001193125-26-115928cik 0001707502
“In December 2024, in connection with the execution of our collaboration, patent and know-how license agreement with Mayo Foundation for Medical Education and Research ("Mayo"), we issued 364,990 shares of our common stock to Mayo in a private placement.”
FILING10-K0001193125-26-115928cik 0001707502
“We, and our subsidiary AavantiBio Inc. ("AavantiBio"), have entered into several license agreements with the University of Florida Research Foundation, Inc. ("UFRF").”
FILING10-K0001193125-26-115928cik 0001707502
Watchlist prices, news filtered to it, and its next report on your desk.
Solid Biosciences Inc. has 8 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Solid Biosciences Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Solid Biosciences Inc.. Customers appear here when Solid Biosciences Inc. names them, or when a company names Solid Biosciences Inc. as a supplier in its own annual report.
SLDB (Solid Biosciences Inc.) has 8 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: JEF −2.47%, in financials.